ATLAS CROSSING LLC

Lobbying for NOVOZYMES NORTH AMERICA INC. · Biosolutions company.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · North Carolina · House · Senate · $50,000.00 income · posted Oct 20, 2025

Lobbying activity 1

Health Issues

Issues related to the expansion of HSA for dietary supplements. Issues related to the benefits of dietary supplements. Issues related to the Generally Recognized as Safe designation.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.